Nova Eye Medical Limited Stock

Nova Eye Medical Limited is an Australia-based medical technology company. The Company’s principal activities include the design, development, manufacture, marketing, sale, and distribution of surgical devices for the treatment of glaucoma, a cause of blindness. The Company is also engaged in the commercialization of its ophthalmic laser, 2RT. The Company’s segments include AlphaRET and Glaucoma surgical devices. The Company's AlphaRET segment has 2RT, which is an ophthalmic laser developed for the therapy of patients in the early to intermediate stages of age-related macular degeneration (AMD). 2RT is a patented nano-pause laser device that rejuvenates retinal structures compromised by AMD. The Glaucoma Surgical Devices segment includes the design, manufacture, marketing and sale of the iTrack, iTrack Advance, and the Molteno3 glaucoma surgical device. The Company's manufacturing facilities are located in Fremont, California, and Dunedin, New Zealand.